Cargando…
Comparison between trabectedin and doxorubicin in soft-tissue sarcomas-reply letter
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073790/ https://www.ncbi.nlm.nih.gov/pubmed/35530938 http://dx.doi.org/10.21037/atm-2022-1 |
| _version_ | 1784701364429914112 |
|---|---|
| author | Dang, Jing-Yi Fu, Jun Zhang, Zhao Liu, Dong Cheng, Debing Fan, Hongbin |
| author_facet | Dang, Jing-Yi Fu, Jun Zhang, Zhao Liu, Dong Cheng, Debing Fan, Hongbin |
| author_sort | Dang, Jing-Yi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9073790 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90737902022-05-07 Comparison between trabectedin and doxorubicin in soft-tissue sarcomas-reply letter Dang, Jing-Yi Fu, Jun Zhang, Zhao Liu, Dong Cheng, Debing Fan, Hongbin Ann Transl Med Letter to the Editor AME Publishing Company 2022-04 /pmc/articles/PMC9073790/ /pubmed/35530938 http://dx.doi.org/10.21037/atm-2022-1 Text en 2022 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Letter to the Editor Dang, Jing-Yi Fu, Jun Zhang, Zhao Liu, Dong Cheng, Debing Fan, Hongbin Comparison between trabectedin and doxorubicin in soft-tissue sarcomas-reply letter |
| title | Comparison between trabectedin and doxorubicin in soft-tissue sarcomas-reply letter |
| title_full | Comparison between trabectedin and doxorubicin in soft-tissue sarcomas-reply letter |
| title_fullStr | Comparison between trabectedin and doxorubicin in soft-tissue sarcomas-reply letter |
| title_full_unstemmed | Comparison between trabectedin and doxorubicin in soft-tissue sarcomas-reply letter |
| title_short | Comparison between trabectedin and doxorubicin in soft-tissue sarcomas-reply letter |
| title_sort | comparison between trabectedin and doxorubicin in soft-tissue sarcomas-reply letter |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073790/ https://www.ncbi.nlm.nih.gov/pubmed/35530938 http://dx.doi.org/10.21037/atm-2022-1 |
| work_keys_str_mv | AT dangjingyi comparisonbetweentrabectedinanddoxorubicininsofttissuesarcomasreplyletter AT fujun comparisonbetweentrabectedinanddoxorubicininsofttissuesarcomasreplyletter AT zhangzhao comparisonbetweentrabectedinanddoxorubicininsofttissuesarcomasreplyletter AT liudong comparisonbetweentrabectedinanddoxorubicininsofttissuesarcomasreplyletter AT chengdebing comparisonbetweentrabectedinanddoxorubicininsofttissuesarcomasreplyletter AT fanhongbin comparisonbetweentrabectedinanddoxorubicininsofttissuesarcomasreplyletter |